findmyKOL

Hiral Parekh, MD

Basic profile

University of North Florida

ORCIDNPI
RegionJacksonville, FL · SoutheastSpecialtyHematology / OncologyFocusOncology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Hiral Parekh is an Oncology physician affiliated with University of North Florida. OpenAlex indexes 45 publications with 603 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
45publications

Distinct works indexed by OpenAlex, matched via ORCID.

603citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    87.2%
    Iron, parenteral preparations86.5%
    Ferric carboxymaltose100%
    Part B, office-administered15 patients
    Factor Xa inhibitor0.7%
    Eliquis78%Xarelto22%
    Part D<11 patients

    + 1 more class in this area

  • Sensory organs

    5.6%
    Corticosteroid5.6%
    Dexamethasone sodium phosphate97%Dexamethasone3%
    Part D + Part B25 patients
  • Metabolism & gastrointestinal

    5.1%
    Serotonin-3 Receptor Antagonist5.1%
    Palonosetron hcl48%Granisetron hydrochloride46%Ondansetron Hcl4%Ondansetron Odt2%
    Part D + Part B36 patients
    Corticosteroid0.1%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)0.8% facility · 99.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”